Rezolute, Inc. (RZLT)

USD 2.49

(-9.31%)

Total Assets Summary of Rezolute, Inc.

  • Rezolute, Inc.'s latest annual total assets in 2024 was 132.73 Million USD , up 7.29% from previous year.
  • Rezolute, Inc.'s latest quarterly total assets in 2024 FY was - USD , up 7.29% from previous quarter.
  • Rezolute, Inc. reported annual total assets of 123.72 Million USD in 2023, down -18.83% from previous year.
  • Rezolute, Inc. reported annual total assets of 152.42 Million USD in 2022, up 257.72% from previous year.
  • Rezolute, Inc. reported quarterly total assets of 102.15 Million USD for 2024 Q2, down -9.6% from previous quarter.
  • Rezolute, Inc. reported quarterly total assets of - USD for 2024 FY, up 7.29% from previous quarter.

Annual Total Assets Chart of Rezolute, Inc. (2024 - 2011)

Historical Annual Total Assets of Rezolute, Inc. (2024 - 2011)

Year Total Assets Total Assets Growth
2024 132.73 Million USD 7.29%
2023 123.72 Million USD -18.83%
2022 152.42 Million USD 257.72%
2021 42.6 Million USD 288.59%
2020 10.96 Million USD -10.5%
2019 12.25 Million USD 389.52%
2018 2.5 Million USD -76.45%
2017 10.62 Million USD -2.52%
2016 10.9 Million USD -3.19%
2015 11.26 Million USD 52.11%
2014 7.4 Million USD 570.73%
2013 1.1 Million USD 21411.52%
2012 5132.00 USD 0.0%
2011 - USD 0.0%

Peer Total Assets Comparison of Rezolute, Inc.

Name Total Assets Total Assets Difference
AbCellera Biologics Inc. 1.48 Billion USD 91.08%
Alkermes plc 2.13 Billion USD 93.786%
Agenus Inc. 313.91 Million USD 57.715%
Alnylam Pharmaceuticals, Inc. 3.82 Billion USD 96.534%
Aptorum Group Limited 20.64 Million USD -543.103%
Ardelyx, Inc. 297.57 Million USD 55.394%
Arrowhead Pharmaceuticals, Inc. 765.55 Million USD 82.661%
Bicycle Therapeutics plc 595.34 Million USD 77.704%
BioXcel Therapeutics, Inc. 73.7 Million USD -80.1%
ChromaDex Corporation 54.96 Million USD -141.498%
Chimerix, Inc. 212.77 Million USD 37.616%
Corbus Pharmaceuticals Holdings, Inc. 28.27 Million USD -369.493%
Caribou Biosciences, Inc. 440.96 Million USD 69.899%
CRISPR Therapeutics AG 2.22 Billion USD 94.047%
Precision BioSciences, Inc. 159.78 Million USD 16.926%
Dyadic International, Inc. 8.21 Million USD -1514.955%
Eton Pharmaceuticals, Inc. 31.74 Million USD -318.201%
Fortress Biotech, Inc. 167.52 Million USD 20.766%
Lantern Pharma Inc. 43.64 Million USD -204.111%
HOOKIPA Pharma Inc. 161.33 Million USD 17.727%
Inhibikase Therapeutics, Inc. 14.5 Million USD -815.008%
Incyte Corporation 6.78 Billion USD 98.043%
IO Biotech, Inc. 150.71 Million USD 11.93%
Jaguar Health, Inc. 50.76 Million USD -161.484%
Novavax, Inc. 1.85 Billion USD 92.846%
Janux Therapeutics, Inc. 380.4 Million USD 65.107%
Opthea Limited 188.79 Million USD 29.691%
Ligand Pharmaceuticals Incorporated 833.06 Million USD 84.066%
ContextLogic Inc. 423 Million USD 68.62%
MiMedx Group, Inc. 239.04 Million USD 44.472%
Pyxis Oncology, Inc. 173.72 Million USD 23.594%
TransCode Therapeutics, Inc. 5.16 Million USD -2467.595%
NextCure, Inc. 129.41 Million USD -2.565%
Ocuphire Pharma, Inc. 53.94 Million USD -146.046%
Oncternal Therapeutics, Inc. 36.72 Million USD -261.396%
Outlook Therapeutics, Inc. 32.3 Million USD -310.938%
Vaxcyte, Inc. 1.4 Billion USD 90.572%
PDS Biotechnology Corporation 59.39 Million USD -123.5%
Madrigal Pharmaceuticals, Inc. 640.54 Million USD 79.278%
Pharming Group N.V. 462.85 Million USD 71.322%
Pieris Pharmaceuticals, Inc. 38.68 Million USD -243.167%
Avidity Biosciences, Inc. 628.55 Million USD 78.882%
Reviva Pharmaceuticals Holdings, Inc. 18.92 Million USD -601.434%
Reviva Pharmaceuticals Holdings, Inc. 18.92 Million USD -601.434%
Sangamo Therapeutics, Inc. 165.32 Million USD 19.709%
Sol-Gel Technologies Ltd. 45.28 Million USD -193.102%
Acelyrin, Inc. 742.69 Million USD 82.128%
Salarius Pharmaceuticals, Inc. 6.58 Million USD -1915.282%
SELLAS Life Sciences Group, Inc. 6.4 Million USD -1973.044%
Summit Therapeutics Inc. 202.94 Million USD 34.596%
Sensei Biotherapeutics, Inc. 74.37 Million USD -78.472%
Senti Biosciences, Inc. 119.48 Million USD -11.092%
Stoke Therapeutics, Inc. 228.34 Million USD 41.869%
Syros Pharmaceuticals, Inc. 168.17 Million USD 21.072%
Alaunos Therapeutics, Inc. 8.26 Million USD -1506.402%
Telomir Pharmaceuticals, Inc. Common Stock 4.77 Million USD -2680.55%
Entrada Therapeutics, Inc. 469.19 Million USD 71.709%
VistaGen Therapeutics, Inc. 123.65 Million USD -7.346%
Wave Life Sciences Ltd. 274.94 Million USD 51.723%
Sorrento Therapeutics, Inc. 472.84 Million USD 71.928%
TRACON Pharmaceuticals, Inc. 10.1 Million USD -1213.577%
Barinthus Biotherapeutics plc 214.5 Million USD 38.12%
Psyence Biomedical Ltd. 1.13 Million USD -11624.237%
Phathom Pharmaceuticals, Inc. 413.84 Million USD 67.926%
Immix Biopharma, Inc. 19.92 Million USD -566.178%
Keros Therapeutics, Inc. 370.02 Million USD 64.128%
MEI Pharma, Inc. 41.37 Million USD -220.815%
Windtree Therapeutics, Inc. 32.4 Million USD -309.606%
Xeris Biopharma Holdings, Inc. 340.79 Million USD 61.051%
Rigel Pharmaceuticals, Inc. 117.22 Million USD -13.233%
Fortress Biotech, Inc. 167.52 Million USD 20.766%
Precigen, Inc. 151.04 Million USD 12.12%
Clearside Biomedical, Inc. 34.01 Million USD -290.196%
AlloVir, Inc. 190.79 Million USD 30.43%
C4 Therapeutics, Inc. 376.45 Million USD 64.74%
Fate Therapeutics, Inc. 506.21 Million USD 73.779%
ImmuCell Corporation 43.8 Million USD -202.996%
IDEAYA Biosciences, Inc. 649.31 Million USD 79.557%
Onconetix, Inc. 88.82 Million USD -49.443%
PureTech Health plc 693.97 Million USD 80.873%
VYNE Therapeutics Inc. 97.68 Million USD -35.883%
Elevation Oncology, Inc. 89.09 Million USD -48.99%
Kintara Therapeutics, Inc. 6.2 Million USD -2040.229%
Seer, Inc. 436.26 Million USD 69.575%
Verrica Pharmaceuticals Inc. 81.59 Million USD -62.674%
Innoviva, Inc. 1.24 Billion USD 89.326%
Aadi Bioscience, Inc. 132.42 Million USD -0.237%
ESSA Pharma Inc. 149.12 Million USD 10.988%
GlycoMimetics, Inc. 45.31 Million USD -192.911%
GT Biopharma, Inc. 14.1 Million USD -840.797%
Inhibrx Biosciences, Inc. 307.89 Million USD 56.889%
Akebia Therapeutics, Inc. 241.7 Million USD 45.083%
Catalyst Pharmaceuticals, Inc. 471.9 Million USD 71.872%
Longboard Pharmaceuticals, Inc. 50.69 Million USD -161.824%
Orchestra BioMed Holdings, Inc. 95.21 Million USD -39.412%
Alzamend Neuro, Inc. 631.58 Thousand USD -20916.39%
Rocket Pharmaceuticals, Inc. 566.34 Million USD 76.562%
Aptose Biosciences Inc. 12.92 Million USD -927.174%
ZyVersa Therapeutics, Inc. 22.11 Million USD -500.232%
Soligenix, Inc. 9.79 Million USD -1254.829%
Century Therapeutics, Inc. 360.69 Million USD 63.199%
Kura Oncology, Inc. 448.93 Million USD 70.433%
TScan Therapeutics, Inc. 272.14 Million USD 51.226%
Intensity Therapeutics, Inc. 17.29 Million USD -667.488%
Ocean Biomedical, Inc. 110.91 Million USD -19.678%
CytomX Therapeutics, Inc. 205.15 Million USD 35.298%
Autolus Therapeutics plc 375.38 Million USD 64.639%
Mineralys Therapeutics, Inc. 251.63 Million USD 47.25%
EyePoint Pharmaceuticals, Inc. 355.18 Million USD 62.629%
Eterna Therapeutics Inc. 49.13 Million USD -170.164%
Adaptive Biotechnologies Corporation 661.13 Million USD 79.923%
GRI Bio, Inc. 2.95 Million USD -4390.426%
Xenetic Biosciences, Inc. 10.6 Million USD -1151.619%
Tenaya Therapeutics, Inc. 170.51 Million USD 22.155%
IGM Biosciences, Inc. 423.41 Million USD 68.651%
INmune Bio, Inc. 57 Million USD -132.868%
Heron Therapeutics, Inc. 222.5 Million USD 40.345%
SAB Biotherapeutics, Inc. 83.94 Million USD -58.131%
Pasithea Therapeutics Corp. 26.11 Million USD -408.243%
Entero Therapeutics, Inc. 6.88 Million USD -1828.421%
Milestone Pharmaceuticals Inc. 75.22 Million USD -76.451%
X4 Pharmaceuticals, Inc. 147.25 Million USD 9.861%
Atara Biotherapeutics, Inc. 165.5 Million USD 19.798%
Coherus BioSciences, Inc. 629.6 Million USD 78.917%
Verastem, Inc. 149.71 Million USD 11.342%
Abeona Therapeutics Inc. 64 Million USD -107.395%
Pliant Therapeutics, Inc. 512.15 Million USD 74.083%
Tonix Pharmaceuticals Holding Corp. 154.45 Million USD 14.062%
Histogen Inc. 19.07 Million USD -595.942%
Aprea Therapeutics, Inc. 22.65 Million USD -486.031%
Surrozen, Inc. 46.08 Million USD -188.058%
Organovo Holdings, Inc. 6.34 Million USD -1990.676%
Lixte Biotechnology Holdings, Inc. 4.3 Million USD -2980.731%
Ovid Therapeutics Inc. 144.02 Million USD 7.839%
Panbela Therapeutics, Inc. 11.8 Million USD -1024.699%
CASI Pharmaceuticals, Inc. 75.26 Million USD -76.353%
Cadrenal Therapeutics, Inc. Common Stock 8.51 Million USD -1458.083%
Centessa Pharmaceuticals plc 362.96 Million USD 63.43%
Hepion Pharmaceuticals, Inc. 18.09 Million USD -633.581%
Arcturus Therapeutics Holdings Inc. 429.4 Million USD 69.088%
BioRestorative Therapies, Inc. 12.61 Million USD -952.489%
Apollomics, Inc. 55.38 Million USD -139.654%
Amarin Corporation plc 831.68 Million USD 84.04%
Mesoblast Limited 669.15 Million USD 80.163%
Turnstone Biologics Corp. 112.81 Million USD -17.659%
Kymera Therapeutics, Inc. 575.75 Million USD 76.946%
Synaptogenix, Inc. 31.11 Million USD -326.62%
Tiziana Life Sciences Ltd 12.18 Million USD -989.437%
Aurinia Pharmaceuticals Inc. 548.06 Million USD 75.781%
BriaCell Therapeutics Corp. 5.87 Million USD -2160.407%
Monopar Therapeutics Inc. 7.34 Million USD -1707.136%
Exelixis, Inc. 2.94 Billion USD 95.489%
Better Therapeutics, Inc. 22.94 Million USD -478.551%
Nurix Therapeutics, Inc. 364.53 Million USD 63.588%
Apellis Pharmaceuticals, Inc. 788.73 Million USD 83.171%
NLS Pharmaceutics AG 1.84 Million USD -7088.024%
Dermata Therapeutics, Inc. 7.97 Million USD -1563.656%
Aridis Pharmaceuticals, Inc. 14.69 Million USD -803.28%
Gritstone bio, Inc. 177.76 Million USD 25.332%
Jasper Therapeutics, Inc. 95.38 Million USD -39.166%
TNF Pharmaceuticals, Inc. 17.86 Million USD -643.114%
Avid Bioservices, Inc. 336.55 Million USD 60.56%
Insmed Incorporated 1.32 Billion USD 90.019%
Virpax Pharmaceuticals, Inc. 9.62 Million USD -1278.607%
MediWound Ltd. 66.45 Million USD -99.728%
OmniAb, Inc. 401.98 Million USD 66.98%
Alector, Inc. 621.82 Million USD 78.654%
Seres Therapeutics, Inc. 358.6 Million USD 62.985%
Checkpoint Therapeutics, Inc. 5.37 Million USD -2368.148%
Viracta Therapeutics, Inc. 56.69 Million USD -134.137%
Zai Lab Limited 1.03 Billion USD 87.191%
Revance Therapeutics, Inc. 478.45 Million USD 72.257%
Aura Biosciences, Inc. 255.07 Million USD 47.962%
Lyell Immunopharma, Inc. 750.02 Million USD 82.302%
Immunic, Inc. 54.29 Million USD -144.456%
Tarsus Pharmaceuticals, Inc. 266.22 Million USD 50.141%
Veracyte, Inc. 1.13 Billion USD 88.334%
InMed Pharmaceuticals Inc. 11.82 Million USD -1022.722%
FibroGen, Inc. 423.52 Million USD 68.659%
SeaStar Medical Holding Corporation 3.51 Million USD -3678.451%
Adial Pharmaceuticals, Inc. 4.73 Million USD -2702.366%
Sonnet BioTherapeutics Holdings, Inc. 5.42 Million USD -2344.747%
Jazz Pharmaceuticals plc 11.39 Billion USD 98.835%
Cyclacel Pharmaceuticals, Inc. 8.8 Million USD -1407.518%
Amylyx Pharmaceuticals, Inc. 517.45 Million USD 74.348%
TG Therapeutics, Inc. 329.58 Million USD 59.726%
Galecto, Inc. 38.22 Million USD -247.234%
Calithera Biosciences, Inc. 28.67 Million USD -362.885%
Fortrea Holdings Inc. 4.35 Billion USD 96.954%
KalVista Pharmaceuticals, Inc. 235.4 Million USD 43.613%
Aptevo Therapeutics Inc. 24.84 Million USD -434.325%
XBiotech Inc. 227.24 Million USD 41.588%
Jasper Therapeutics, Inc. 95.38 Million USD -39.166%
Lyra Therapeutics, Inc. 142.6 Million USD 6.917%
Foghorn Therapeutics Inc. 285.91 Million USD 53.575%
Y-mAbs Therapeutics, Inc. 127.86 Million USD -3.807%
Theravance Biopharma, Inc. 381.99 Million USD 65.252%
Ultragenyx Pharmaceutical Inc. 1.49 Billion USD 91.098%
Metagenomi, Inc. Common Stock 364.84 Million USD 63.618%
Vaxxinity, Inc. 44.35 Million USD -199.274%
BioCryst Pharmaceuticals, Inc. 516.96 Million USD 74.324%
Gain Therapeutics, Inc. 18.6 Million USD -613.282%
Cartesian Therapeutics, Inc. 305.05 Million USD 56.487%
NexImmune, Inc. 8.59 Million USD -1444.54%
Creative Medical Technology Holdings, Inc. 10.71 Million USD -1138.774%
Marker Therapeutics, Inc. 17.12 Million USD -674.998%
Regeneron Pharmaceuticals, Inc. 33.08 Billion USD 99.599%
Chemomab Therapeutics Ltd. 22.15 Million USD -499.234%
Scopus BioPharma Inc. 392.26 Thousand USD -33738.604%
RAPT Therapeutics, Inc. 173.32 Million USD 23.419%
Ainos, Inc. 31.84 Million USD -316.864%
Pluri Inc. 39.52 Million USD -235.813%
Prothena Corporation plc 696.38 Million USD 80.939%
Adaptimmune Therapeutics plc 282.61 Million USD 53.033%
Celularity Inc. 143.88 Million USD 7.75%
Rallybio Corporation 115.62 Million USD -14.805%
Cue Biopharma, Inc. 61.53 Million USD -115.727%
MeiraGTx Holdings plc 458.16 Million USD 71.029%
Omeros Corporation 378.26 Million USD 64.909%
Humacyte, Inc. 128.22 Million USD -3.52%
Immunocore Holdings plc 597 Million USD 77.766%
Cocrystal Pharma, Inc. 31.25 Million USD -324.636%
Cidara Therapeutics, Inc. 68.53 Million USD -93.692%
Blueprint Medicines Corporation 1.04 Billion USD 87.349%
CalciMedica, Inc. 12.18 Million USD -989.348%
Cabaletta Bio, Inc. 253.65 Million USD 47.669%
Marinus Pharmaceuticals, Inc. 170.9 Million USD 22.334%
Scholar Rock Holding Corporation 311.03 Million USD 57.324%
Sana Biotechnology, Inc. 565.29 Million USD 76.519%
Pulmatrix, Inc. 33.95 Million USD -290.886%
Elicio Therapeutics, Inc. 27.14 Million USD -388.974%
Vigil Neuroscience, Inc. 140.85 Million USD 5.765%
Intellia Therapeutics, Inc. 1.3 Billion USD 89.797%
Adlai Nortye Ltd. American Depositary Shares 130.18 Million USD -1.957%
Cytokinetics, Incorporated 824.31 Million USD 83.897%
Eloxx Pharmaceuticals, Inc. 21.12 Million USD -528.4%
Nutriband Inc. 7.51 Million USD -1665.788%
Protara Therapeutics, Inc. 78.95 Million USD -68.119%
Vor Biopharma Inc. 209.82 Million USD 36.74%
Roivant Sciences Ltd. 7.22 Billion USD 98.162%
Evogene Ltd. 51.1 Million USD -159.754%
ProKidney Corp. 420.55 Million USD 68.437%
Applied Therapeutics, Inc. 54.83 Million USD -142.075%
Hoth Therapeutics, Inc. 9.52 Million USD -1294.256%
BridgeBio Pharma, Inc. 546.38 Million USD 75.706%
CorMedix Inc. 82.05 Million USD -61.756%
BioLineRx Ltd. 63.92 Million USD -107.645%
Tango Therapeutics, Inc. 402.56 Million USD 67.027%
Galectin Therapeutics Inc. 28.2 Million USD -370.699%
Atai Life Sciences N.V. 293.47 Million USD 54.771%
Renovaro Biosciences Inc. 163.12 Million USD 18.631%
Aerovate Therapeutics, Inc. 127.41 Million USD -4.174%
Zentalis Pharmaceuticals, Inc. 562.02 Million USD 76.382%
Sagimet Biosciences Inc. 96.71 Million USD -37.24%
MediciNova, Inc. 66.26 Million USD -100.297%
Praxis Precision Medicines, Inc. 87.94 Million USD -50.927%
Cardio Diagnostics Holdings, Inc. 4.46 Million USD -2874.589%
GeoVax Labs, Inc. 9.28 Million USD -1329.86%
Axsome Therapeutics, Inc. 588.23 Million USD 77.435%
Biomea Fusion, Inc. 199.92 Million USD 33.607%
PTC Therapeutics, Inc. 1.9 Billion USD 93.026%
Mereo BioPharma Group plc 66.49 Million USD -99.608%
Cullinan Oncology, Inc. 485.09 Million USD 72.637%
Syndax Pharmaceuticals, Inc. 612.88 Million USD 78.342%
Absci Corporation 234.48 Million USD 43.391%
NRx Pharmaceuticals, Inc. 7.31 Million USD -1714.586%
4D Molecular Therapeutics, Inc. 339.89 Million USD 60.947%
Dyne Therapeutics, Inc. 165.08 Million USD 19.593%
Kiniksa Pharmaceuticals, Ltd. 526.32 Million USD 74.78%
Ventyx Biosciences, Inc. 277.69 Million USD 52.2%
Allakos Inc. 243.61 Million USD 45.512%
Imunon, Inc. 21.91 Million USD -505.605%
Fulcrum Therapeutics, Inc. 257.69 Million USD 48.49%
Corcept Therapeutics Incorporated 621.51 Million USD 78.643%
BioAtla, Inc. 119.65 Million USD -10.93%
NLS Pharmaceutics AG 1.84 Million USD -7088.024%
Bio-Path Holdings, Inc. 3.22 Million USD -4022.267%
Allogene Therapeutics, Inc. 642.83 Million USD 79.351%
Larimar Therapeutics, Inc. 95.93 Million USD -38.361%
XOMA Corporation 234.3 Million USD 43.348%
Kezar Life Sciences, Inc. 221.23 Million USD 40.002%
Cara Therapeutics, Inc. 125.84 Million USD -5.477%
aTyr Pharma, Inc. 122.06 Million USD -8.741%
Aligos Therapeutics, Inc. 153.9 Million USD 13.753%
Akero Therapeutics, Inc. 580.27 Million USD 77.125%
Viridian Therapeutics, Inc. 490.42 Million USD 72.934%
Eliem Therapeutics, Inc. 110.46 Million USD -20.158%
EyeGate Pharmaceuticals, Inc. 15.15 Million USD -775.715%
Akari Therapeutics, Plc 4.35 Million USD -2947.922%
Tevogen Bio Holdings Inc. 17.03 Million USD -679.095%
Halozyme Therapeutics, Inc. 1.73 Billion USD 92.342%
Lexaria Bioscience Corp. 3.08 Million USD -4204.073%
UroGen Pharma Ltd. 178.31 Million USD 25.559%
Sutro Biopharma, Inc. 470.73 Million USD 71.802%
ZIVO Bioscience, Inc. 555.71 Thousand USD -23785.805%
Orgenesis Inc. 14.55 Million USD -812.156%
Entera Bio Ltd. 11.76 Million USD -1028.236%
GH Research PLC 226.3 Million USD 41.345%
Lisata Therapeutics, Inc. 54.69 Million USD -142.69%
Reneo Pharmaceuticals, Inc. 107.43 Million USD -23.55%
Xencor, Inc. 952.69 Million USD 86.067%
60 Degrees Pharmaceuticals, Inc. 7.78 Million USD -1605.305%
Replimune Group, Inc. 487.72 Million USD 72.784%
Coeptis Therapeutics Holdings, Inc. 8.07 Million USD -1544.598%
Vanda Pharmaceuticals Inc. 648.44 Million USD 79.53%
Lexaria Bioscience Corp. 3.08 Million USD -4204.073%
Portage Biotech Inc. 7.77 Million USD -1606.35%
Cardio Diagnostics Holdings, Inc. 4.46 Million USD -2874.589%
Olema Pharmaceuticals, Inc. 276.94 Million USD 52.071%
OncoCyte Corporation 74.89 Million USD -77.238%
Qualigen Therapeutics, Inc. 2.03 Million USD -6428.323%
Processa Pharmaceuticals, Inc. 5.78 Million USD -2193.852%
Purple Biotech Ltd. 44.3 Million USD -199.619%
CollPlant Biotechnologies Ltd. 34.12 Million USD -288.961%
scPharmaceuticals Inc. 94.47 Million USD -40.494%
ProMIS Neurosciences, Inc. 18.04 Million USD -635.591%
HilleVax, Inc. 344.43 Million USD 61.462%
NeuroSense Therapeutics Ltd. 3.17 Million USD -4079.377%
Tharimmune, Inc. 10.94 Million USD -1112.609%
Genprex, Inc. 10.67 Million USD -1143.952%
Neumora Therapeutics, Inc. Common Stock 496.19 Million USD 73.249%
Atossa Therapeutics, Inc. 96.25 Million USD -37.906%
XTL Biopharmaceuticals Ltd. 2.42 Million USD -5371.434%
Virios Therapeutics, Inc. 4.16 Million USD -3086.625%
OKYO Pharma Limited 1.54 Million USD -8512.217%
Savara Inc. 177.56 Million USD 25.246%
Curis, Inc. 77.28 Million USD -71.757%
Daré Bioscience, Inc. 21.28 Million USD -523.699%
Carmell Therapeutics Corporation 63.94 Million USD -107.568%
Titan Pharmaceuticals, Inc. 8.08 Million USD -1541.566%
Achieve Life Sciences, Inc. 19.37 Million USD -585.236%
BeiGene, Ltd. 5.8 Billion USD 97.714%
Kiromic BioPharma, Inc. 12.16 Million USD -990.78%
Revolution Medicines, Inc. Warrant 2.08 Billion USD 93.645%
Protagonist Therapeutics, Inc. 357.95 Million USD 62.918%
Erasca, Inc. 395.29 Million USD 66.421%
bluebird bio, Inc. 619.16 Million USD 78.562%
Protagenic Therapeutics, Inc. 4.32 Million USD -2970.221%
BioMarin Pharmaceutical Inc. 6.84 Billion USD 98.06%
DBV Technologies S.A. 182.98 Million USD 27.461%
Protagenic Therapeutics, Inc. 4.32 Million USD -2970.221%
Moderna, Inc. 18.42 Billion USD 99.28%
Vincerx Pharma, Inc. 18.21 Million USD -628.644%
Fresh Tracks Therapeutics, Inc. 11.58 Million USD -1045.667%
Molecular Templates, Inc. 35.38 Million USD -275.143%
Acrivon Therapeutics, Inc. Common Stock 138.26 Million USD 3.998%
Travere Therapeutics, Inc. 788.91 Million USD 83.175%
Monte Rosa Therapeutics, Inc. 303.75 Million USD 56.301%
Spruce Biosciences, Inc. 103.94 Million USD -27.698%
Celldex Therapeutics, Inc. 465.62 Million USD 71.493%
Cogent Biosciences, Inc. 313.43 Million USD 57.651%
MacroGenics, Inc. 306.82 Million USD 56.738%
RenovoRx, Inc. 1.46 Million USD -8954.366%
Adicet Bio, Inc. 207.29 Million USD 35.967%
Prime Medicine, Inc. 193.85 Million USD 31.526%
Aditxt, Inc. 44.57 Million USD -197.761%
Adagene Inc. 115.72 Million USD -14.697%
Estrella Immunopharma, Inc. 4.45 Million USD -2880.049%
Quantum-Si incorporated 298.25 Million USD 55.495%
Maravai LifeSciences Holdings, Inc. 1.48 Billion USD 91.076%
Acurx Pharmaceuticals, Inc. 7.7 Million USD -1621.817%
Voyager Therapeutics, Inc. 351.28 Million USD 62.213%
SciSparc Ltd. 11.18 Million USD -1087.06%
Vericel Corporation 353.65 Million USD 62.467%
Revelation Biosciences, Inc. 12.21 Million USD -986.885%
Minerva Neurosciences, Inc. 56.9 Million USD -133.279%
Generation Bio Co. 374.75 Million USD 64.581%
Astria Therapeutics, Inc. 254.66 Million USD 47.878%
Black Diamond Therapeutics, Inc. 158.56 Million USD 16.29%
Arcutis Biotherapeutics, Inc. 341.36 Million USD 61.116%
Invivyd, Inc. 229.18 Million USD 42.082%
Relay Therapeutics, Inc. 843.98 Million USD 84.272%
Quoin Pharmaceuticals, Ltd. 12.16 Million USD -990.753%
Spero Therapeutics, Inc. 182.39 Million USD 27.224%
Artelo Biosciences, Inc. 20.42 Million USD -549.907%
2seventy bio, Inc. 565.42 Million USD 76.524%
ADMA Biologics, Inc. 329.18 Million USD 59.677%
Clene Inc. 52.34 Million USD -153.6%
Capricor Therapeutics, Inc. 58.73 Million USD -125.996%
Boundless Bio, Inc. Common Stock 129.89 Million USD -2.189%
GeoVax Labs, Inc. 9.28 Million USD -1329.86%
Recursion Pharmaceuticals, Inc. 653.69 Million USD 79.694%
Citius Pharmaceuticals, Inc. 103.61 Million USD -28.111%
Contineum Therapeutics, Inc. Class A Common Stock 130.38 Million USD -1.803%
Relmada Therapeutics, Inc. 97.55 Million USD -36.068%
Finch Therapeutics Group, Inc. 70.99 Million USD -86.961%
ALX Oncology Holdings Inc. 242.55 Million USD 45.275%
Vir Biotechnology, Inc. 1.96 Billion USD 93.228%
Evaxion Biotech A/S 12.88 Million USD -929.878%
Ocular Therapeutix, Inc. 252.06 Million USD 47.339%
Verve Therapeutics, Inc. 752.68 Million USD 82.365%
Trevena, Inc. 40.6 Million USD -226.898%
Surrozen, Inc. 46.08 Million USD -188.058%
Tyra Biosciences, Inc. 225.85 Million USD 41.23%
Cingulate Inc. 3.49 Million USD -3701.788%
Galmed Pharmaceuticals Ltd. 16.62 Million USD -698.226%
Unity Biotechnology, Inc. 65.69 Million USD -102.066%
Tenax Therapeutics, Inc. 11.68 Million USD -1035.997%
Terns Pharmaceuticals, Inc. 268.51 Million USD 50.567%
ACADIA Pharmaceuticals Inc. 748.95 Million USD 82.277%
Connect Biopharma Holdings Limited 125.89 Million USD -5.437%
Clearmind Medicine Inc. 4.32 Million USD -2969.497%
Kronos Bio, Inc. 213.27 Million USD 37.764%
Bolt Biotherapeutics, Inc. 159.78 Million USD 16.927%
CERo Therapeutics Holdings, Inc. 8.56 Million USD -1450.555%
Viking Therapeutics, Inc. 368.49 Million USD 63.978%
Statera Biopharma, Inc. 21.16 Million USD -527.015%
ImmunityBio, Inc. 504.45 Million USD 73.687%
Korro Bio, Inc. 221.66 Million USD 40.118%
Kineta, Inc. 10.28 Million USD -1191.09%
BioVie Inc. 25.2 Million USD -426.56%
Codexis, Inc. 136.56 Million USD 2.8%
Celularity Inc. 143.88 Million USD 7.75%
Crinetics Pharmaceuticals, Inc. 635.35 Million USD 79.108%
Celcuity Inc. 191.21 Million USD 30.584%
Virax Biolabs Group Limited 5.48 Million USD -2320.455%
Cibus, Inc. 544.41 Million USD 75.618%
Eledon Pharmaceuticals, Inc. 125.89 Million USD -5.436%
eFFECTOR Therapeutics, Inc. 20.54 Million USD -546.111%
IN8bio, Inc. 33.7 Million USD -293.773%
Kodiak Sciences Inc. 479.37 Million USD 72.31%
Annexon, Inc. 297.67 Million USD 55.409%
Adverum Biotechnologies, Inc. 173.01 Million USD 23.278%
Assembly Biosciences, Inc. 137.46 Million USD 3.442%
Avalo Therapeutics, Inc. 20.99 Million USD -532.292%
Ionis Pharmaceuticals, Inc. 2.99 Billion USD 95.561%
Eyenovia, Inc. 28.77 Million USD -361.223%
Puma Biotechnology, Inc. 230.52 Million USD 42.42%
Conduit Pharmaceuticals Inc. 7.22 Million USD -1737.445%
Xilio Therapeutics, Inc. 60.92 Million USD -117.866%
Arcellx, Inc. 825.13 Million USD 83.913%
Cardiff Oncology, Inc. 81.63 Million USD -62.594%
Enanta Pharmaceuticals, Inc. 462.27 Million USD 71.286%
Regulus Therapeutics Inc. 30.75 Million USD -331.665%
Moolec Science SA 24.05 Million USD -451.891%
Acumen Pharmaceuticals, Inc. 310.12 Million USD 57.199%
Geron Corporation 394.07 Million USD 66.317%
LAVA Therapeutics N.V. 101.71 Million USD -30.505%
Royalty Pharma plc 16.38 Billion USD 99.19%
Atea Pharmaceuticals, Inc. 594.96 Million USD 77.69%
Greenwich LifeSciences, Inc. 6.99 Million USD -1797.648%
TFF Pharmaceuticals, Inc. 12.02 Million USD -1003.629%
Mersana Therapeutics, Inc. 226.06 Million USD 41.282%
Humacyte, Inc. 128.22 Million USD -3.52%
Structure Therapeutics Inc. 482.01 Million USD 72.462%
89bio, Inc. 596.26 Million USD 77.739%
PMV Pharmaceuticals, Inc. 252.15 Million USD 47.358%
Avenue Therapeutics, Inc. 1.85 Million USD -7074.973%
Genelux Corporation 27.89 Million USD -375.879%
Trevi Therapeutics, Inc. 89.4 Million USD -48.47%
Lexicon Pharmaceuticals, Inc. 229.42 Million USD 42.145%
Notable Labs, Ltd. 19.54 Million USD -579.274%
Liquidia Corporation 120.43 Million USD -10.218%
Mustang Bio, Inc. 17.74 Million USD -648.151%
Immunovant, Inc. 666.71 Million USD 80.091%
Quantum-Si incorporated 298.25 Million USD 55.495%
Arbutus Biopharma Corporation 144.4 Million USD 8.078%
DiaMedica Therapeutics Inc. 54.16 Million USD -145.083%
Vera Therapeutics, Inc. 175.54 Million USD 24.386%
Acasti Pharma Inc. 73.3 Million USD -81.087%
MiNK Therapeutics, Inc. 4.55 Million USD -2815.835%
Pasithea Therapeutics Corp. 26.11 Million USD -408.243%
Xenon Pharmaceuticals Inc. 964.79 Million USD 86.242%
Elevai Labs, Inc. Common Stock 5.18 Million USD -2457.593%
NeuroBo Pharmaceuticals, Inc. 22.78 Million USD -482.665%
Tempest Therapeutics, Inc. 51.6 Million USD -157.227%
Soleno Therapeutics, Inc. 180.69 Million USD 26.539%
PepGen Inc. 143.05 Million USD 7.211%
Moleculin Biotech, Inc. 38.21 Million USD -247.324%
United Therapeutics Corporation 7.16 Billion USD 98.148%
Nuvectis Pharma, Inc. 19.18 Million USD -591.879%
Solid Biosciences Inc. 164.93 Million USD 19.524%
BriaCell Therapeutics Corp. 5.87 Million USD -2160.407%
Immuneering Corporation 102.58 Million USD -29.393%
Lixte Biotechnology Holdings, Inc. 4.3 Million USD -2980.731%
Silo Pharma, Inc. 7.74 Million USD -1613.589%
Belite Bio, Inc 94.64 Million USD -40.252%
XOMA Corporation 234.3 Million USD 43.348%
ARS Pharmaceuticals, Inc. 233.18 Million USD 43.077%
Bionomics Limited 27.64 Million USD -380.077%
Apogee Therapeutics, Inc. 401.4 Million USD 66.932%
Alpha Tau Medical Ltd. 107.38 Million USD -23.605%
uniQure N.V. 831.68 Million USD 84.04%
Cassava Sciences, Inc. 151.66 Million USD 12.479%
Estrella Immunopharma, Inc. 4.45 Million USD -2880.049%
Poseida Therapeutics, Inc. 273.88 Million USD 51.535%
Forte Biosciences, Inc. 38.98 Million USD -240.526%
Anebulo Pharmaceuticals, Inc. 4.07 Million USD -3158.858%
Enlivex Therapeutics Ltd. 36.83 Million USD -260.395%
Conduit Pharmaceuticals Inc. 7.22 Million USD -1737.445%
SeaStar Medical Holding Corporation 3.51 Million USD -3678.451%
FibroBiologics, Inc. Common Stock 11.82 Million USD -1022.891%
Altimmune, Inc. 210.64 Million USD 36.984%
Amicus Therapeutics, Inc. 777.88 Million USD 82.936%
Alpha Tau Medical Ltd. 107.38 Million USD -23.605%
Compugen Ltd. 121.33 Million USD -9.398%
Peak Bio, Inc. 2.59 Million USD -5012.318%
Zevra Therapeutics, Inc. 172.32 Million USD 22.974%
Benitec Biopharma Inc. 52.21 Million USD -154.237%
Spyre Therapeutics, Inc. 341.85 Million USD 61.172%
NKGen Biotech, Inc. Common Stock 34.77 Million USD -281.724%
Zura Bio Limited 100.84 Million USD -31.627%
PolyPid Ltd. 15.37 Million USD -763.499%
Aileron Therapeutics, Inc. 119.28 Million USD -11.276%
NKGen Biotech, Inc. Warrants 34.77 Million USD -281.724%
Instil Bio, Inc. 325.63 Million USD 59.237%
argenx SE 4.54 Billion USD 97.078%
Immunome, Inc. 148.54 Million USD 10.639%
Compass Therapeutics, Inc. 156.87 Million USD 15.387%
Verona Pharma plc 308.12 Million USD 56.921%
enGene Holdings Inc. Warrants 86.95 Million USD -52.643%
Shattuck Labs, Inc. 159.56 Million USD 16.813%
CervoMed Inc. 9.97 Million USD -1231.028%
LENZ Therapeutics, Inc. 188.45 Million USD 29.566%
Plus Therapeutics, Inc. 11.38 Million USD -1065.587%
Dianthus Therapeutics, Inc. 179.4 Million USD 26.013%
Moolec Science SA 24.05 Million USD -451.891%
Enveric Biosciences, Inc. 6.11 Million USD -2069.799%
Inovio Pharmaceuticals, Inc. 172.94 Million USD 23.249%
AnaptysBio, Inc. 452.38 Million USD 70.659%
Design Therapeutics, Inc. 289.64 Million USD 54.172%
Leap Therapeutics, Inc. 72.82 Million USD -82.268%
NeurAxis, Inc. 509.49 Thousand USD -25952.507%
Seelos Therapeutics, Inc. 5.41 Million USD -2349.926%
Lumos Pharma, Inc. 40.63 Million USD -226.633%
Achilles Therapeutics plc 161.45 Million USD 17.788%
enGene Holdings Inc. Common Stock 86.95 Million USD -52.643%
180 Life Sciences Corp. 5.25 Million USD -2423.769%
Opiant Pharmaceuticals, Inc. 70.42 Million USD -88.472%
CERo Therapeutics Holdings, Inc. 8.56 Million USD -1450.555%
Nutriband Inc. 7.51 Million USD -1665.788%
ORIC Pharmaceuticals, Inc. 254.68 Million USD 47.882%
CG Oncology, Inc. Common stock 199.3 Million USD 33.399%
Fractyl Health, Inc. Common Stock 76.21 Million USD -74.168%
Rani Therapeutics Holdings, Inc. 57.91 Million USD -129.189%
MoonLake Immunotherapeutics 526.54 Million USD 74.791%
Palisade Bio, Inc. 14.05 Million USD -844.613%
Tourmaline Bio, Inc. 210.29 Million USD 36.881%
Beam Therapeutics Inc. 1.45 Billion USD 90.907%
Neurogene Inc. 222.57 Million USD 40.362%
Mirum Pharmaceuticals, Inc. 646.62 Million USD 79.472%
AEON Biopharma, Inc. 6.84 Million USD -1839.182%
CARGO Therapeutics, Inc. Common Stock 453.03 Million USD 70.701%
Sesen Bio, Inc. 189.17 Million USD 29.833%
Enliven Therapeutics, Inc. 271.86 Million USD 51.176%
Kiora Pharmaceuticals, Inc. 13.71 Million USD -868.044%
Iovance Biotherapeutics, Inc. 780.35 Million USD 82.99%
Taysha Gene Therapies, Inc. 266.99 Million USD 50.285%
Athira Pharma, Inc. 160.24 Million USD 17.166%
Vaccinex, Inc. 3.63 Million USD -3555.66%
HCW Biologics Inc. 28.51 Million USD -365.521%
XOMA Corporation 234.3 Million USD 43.348%
Nektar Therapeutics 398.03 Million USD 66.652%
Arvinas, Inc. 1.3 Billion USD 89.825%
Tevogen Bio Holdings Inc. 17.03 Million USD -679.095%
Merus N.V. 458.49 Million USD 71.049%
Omega Therapeutics, Inc. 204.36 Million USD 35.049%
Quince Therapeutics, Inc. 180.2 Million USD 26.341%
Clene Inc. 52.34 Million USD -153.6%
Indaptus Therapeutics, Inc. 14.92 Million USD -789.427%
BeyondSpring Inc. 24.8 Million USD -435.057%
Synlogic, Inc. 75.55 Million USD -75.694%
Allarity Therapeutics, Inc. 11.86 Million USD -1019.01%
Phio Pharmaceuticals Corp. 9.36 Million USD -1317.525%
Peak Bio, Inc. 2.59 Million USD -5012.318%
Werewolf Therapeutics, Inc. 174.83 Million USD 24.078%
Krystal Biotech, Inc. 818.35 Million USD 83.78%
Karyopharm Therapeutics Inc. 240.43 Million USD 44.794%
SpringWorks Therapeutics, Inc. 725.78 Million USD 81.711%
Lipella Pharmaceuticals Inc. 3.57 Million USD -3610.667%
MannKind Corporation 475.19 Million USD 72.067%
Ikena Oncology, Inc. 192.09 Million USD 30.899%
Cyclerion Therapeutics, Inc. 13.37 Million USD -892.5%
Gyre Therapeutics, Inc. 116.53 Million USD -13.899%
Gossamer Bio, Inc. 311.91 Million USD 57.445%
CohBar, Inc. 16.36 Million USD -711.07%
Cognition Therapeutics, Inc. 35.16 Million USD -277.491%
NRx Pharmaceuticals, Inc. 7.31 Million USD -1714.586%
Legend Biotech Corporation 1.84 Billion USD 92.82%
Mural Oncology plc 301.74 Million USD 56.01%
Biora Therapeutics, Inc. 31.21 Million USD -325.235%
PaxMedica, Inc. Common Stock 5.68 Million USD -2236.752%
Disc Medicine, Inc. 367.99 Million USD 63.93%
Champions Oncology, Inc. 26.13 Million USD -407.948%
REGENXBIO Inc. 573.97 Million USD 76.874%
Ensysce Biosciences, Inc. 2.7 Million USD -4801.508%
Anavex Life Sciences Corp. 154.38 Million USD 14.023%
Cellectar Biosciences, Inc. 12.07 Million USD -999.218%
Edgewise Therapeutics, Inc. 340.03 Million USD 60.964%
Vaxart, Inc. 91.83 Million USD -44.546%
PharmaCyte Biotech, Inc. 59.9 Million USD -121.583%
Aldeyra Therapeutics, Inc. 148.32 Million USD 10.511%
Cellectis S.A. 334.27 Million USD 60.29%
Longeveron Inc. 12.17 Million USD -989.974%
Repare Therapeutics Inc. 253.9 Million USD 47.721%
Sarepta Therapeutics, Inc. 3.26 Billion USD 95.934%
Inozyme Pharma, Inc. 200.84 Million USD 33.911%
Revolution Medicines, Inc. 2.08 Billion USD 93.645%
Nymox Pharmaceutical Corporation 1.62 Million USD -8068.431%
Third Harmonic Bio, Inc. 277.71 Million USD 52.203%
ArriVent BioPharma, Inc. Common Stock 163.09 Million USD 18.615%
AN2 Therapeutics, Inc. 138.74 Million USD 4.33%
Anixa Biosciences, Inc. 25.52 Million USD -420.089%
Vertex Pharmaceuticals Incorporated 22.73 Billion USD 99.416%
Denali Therapeutics Inc. 1.15 Billion USD 88.497%
Revelation Biosciences, Inc. 12.21 Million USD -986.885%
Veru Inc. 50.59 Million USD -162.347%
Corvus Pharmaceuticals, Inc. 45.55 Million USD -191.39%
Cingulate Inc. 3.49 Million USD -3701.788%
Passage Bio, Inc. 150.54 Million USD 11.829%
Context Therapeutics Inc. 16.06 Million USD -726.366%
Exicure, Inc. 11.58 Million USD -1046.261%
Day One Biopharmaceuticals, Inc. 376.04 Million USD 64.702%
Oramed Pharmaceuticals Inc. 161.64 Million USD 17.882%
Scinai Immunotherapeutics Ltd. 17.47 Million USD -659.713%
Rhythm Pharmaceuticals, Inc. 332.74 Million USD 60.108%
Nuvalent, Inc. 732.38 Million USD 81.876%
ABVC BioPharma, Inc. 14.94 Million USD -788.225%
Carisma Therapeutics, Inc. 89.55 Million USD -48.22%
Unicycive Therapeutics, Inc. 14.19 Million USD -835.36%
OmniAb, Inc. 401.98 Million USD 66.98%
Anew Medical, Inc. 19.45 Million USD -582.244%
Fennec Pharmaceuticals Inc. 26.72 Million USD -396.648%
Lipocine Inc. 23 Million USD -477.09%
Lexeo Therapeutics, Inc. Common Stock 139.8 Million USD 5.057%
Nautilus Biotechnology, Inc. 305.56 Million USD 56.56%
SAB Biotherapeutics, Inc. 83.94 Million USD -58.131%
G1 Therapeutics, Inc. 121.54 Million USD -9.213%
Bellerophon Therapeutics, Inc. 7.93 Million USD -1572.804%
Sage Therapeutics, Inc. 882.27 Million USD 84.955%
Ocugen, Inc. 64.54 Million USD -105.644%
Mind Medicine (MindMed) Inc. 124.54 Million USD -6.581%
Q32 Bio Inc. 306.11 Million USD 56.639%
Brainstorm Cell Therapeutics Inc. 4.2 Million USD -3054.396%
Alumis Inc. Common Stock 89.61 Million USD -48.124%
Equillium, Inc. 50.53 Million USD -162.689%
Kyverna Therapeutics, Inc. 75.19 Million USD -76.524%
Coya Therapeutics, Inc. 41.27 Million USD -221.603%
CNS Pharmaceuticals, Inc. 1.7 Million USD -7704.143%
Galera Therapeutics, Inc. 26.14 Million USD -407.773%
Evelo Biosciences, Inc. 64.44 Million USD -105.982%
Comera Life Sciences Holdings, Inc. 3.72 Million USD -3461.389%
Dominari Holdings Inc. 57.55 Million USD -130.614%
Edesa Biotech, Inc. 8.89 Million USD -1393.031%
vTv Therapeutics Inc. 11.01 Million USD -1104.729%
Bio-Techne Corporation 2.81 Billion USD 95.282%
Agios Pharmaceuticals, Inc. 937.11 Million USD 85.836%
Harmony Biosciences Holdings, Inc. 811.44 Million USD 83.642%
Prelude Therapeutics Incorporated 277.66 Million USD 52.195%
Candel Therapeutics, Inc. 41.7 Million USD -218.299%
iTeos Therapeutics, Inc. 667.58 Million USD 80.117%
Nkarta, Inc. 378.88 Million USD 64.966%
BioCardia, Inc. 2.98 Million USD -4343.823%
Iterum Therapeutics plc 26.25 Million USD -405.491%